Latest News

Shore Capital appointed as Joint Broker to Greencore

READ MORE

To thrive after Brexit, we must turbo-charge forgotten corners of the country

READ MORE

Shore Capital acts as Financial Adviser, Nominated Adviser and Joint Broker on Amryt Pharma’s acquisition of Aegerion Pharmaceuticals, Inc.

READ MORE
SEE ALL NEWS

Message from the Executive Chairman

Featured Service

Research

Within our sector coverage Shore Capital follows industries and stocks from top to bottom. In this respect, we are distinctive in offering competitive and well established analysis in FTSE-100 stocks right down to AIM and FTSE Small-Cap equities.

LEARN MORE